Vermont Disclosure

Guide to Vermont's pharmaceutical marketer price disclosure law

This information is intended for U.S. residents.

33 V.S.A. § 2005a.

Product Name Short Form Long Form Date updated
Aubagio® (teriflunomide) Aubagio Short Form Aubagio Long Form July 22, 2019
Cerdelga (eliglustat) Cerdelga Short Form Cerdelga Long Form July 22, 2019
Multaq (dronedarone) Multaq Short Form Multaq Long Form July 22, 2019
Renvela (sevelamer carbonate) Renvela Short Form Renvela Long Form July 22, 2019
Caprelsa (vandetanib) Caprelsa Short Form Caprelsa Long Form July 22, 2019

Guide to Vermont's Pharmaceutical Marketer Price Disclosure Law, 33 V.S.A. § 2005a. Published by the Vermont Office of the Attorney General.

Please See Full Prescribing Information, including Boxed Warning, for Aubagio, Caprelsa and Multaq.


Vermont Disclosure 2


Get more information about the Sanofi group products.